Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, Morgan Stanley Children's Hospital, New York, NY, USA.
Division of Pediatric Cardiology, Department of Pediatrics, Columbia University Irving Medical Center, Morgan Stanley Children's Hospital, New York, NY, USA. Email:
J Invasive Cardiol. 2024 Sep;36(9). doi: 10.25270/jic/24.00097.
Pulmonary artery (PA) bifurcation stenosis often requires simultaneous stent placement, which may be technically challenging. Limited data exist regarding this practice in infants. We aim to report the procedural outcomes and safety of bifurcation stent placement in infants.
We performed a single-center retrospective review of infants younger than 12 months who underwent simultaneous stent placement for PA bifurcation stenosis from January 1, 2001 through December 31, 2019.
Seventeen infants underwent simultaneous PA bifurcation stent placement. The median age was 6.4 months (1.1-10.1 months), and weight was 5.8 kg (3-10.6 kg). Nine (52.9%) patients had had prior PA intervention. Most stents were placed in central PAs (28, 82.4%), followed by lobar branches (6, 17.6%). All patients received pre-mounted stents. The peak gradient across each branch decreased from 47.4 ± 16 to 18.7 ± 13 mm Hg (P less than .0001). The right ventricle to systemic systolic pressure ratio decreased from systemic (1.0 ± 0.3) to just over half systemic (0.58 ± 0.2) (P = .0001). The minimum vessel diameter increased from 3.6 ± 1.5 to 6.0 ± 1.9 mm (P less than .0001). There were 4 (23.5%) patients with high severity adverse events. There were no procedure-related deaths. The median follow-up period was 83.8 months (5.3 months-19.4 years). All patients had subsequent PA re-intervention at a median time of 8.1 months (2.9 months-8.8 years), and median time to re-operation was 19.1 months (2.9 months-7.5 years).
Simultaneous PA stent placement is an effective strategy for relief of bifurcation stenosis in infants. Future transcatheter interventions are necessary to account for patient growth, but may delay the need for re-operation.
肺动脉(PA)分叉狭窄常需要同时进行支架置入,这可能具有技术挑战性。目前关于婴儿这一治疗方法的数据有限。我们旨在报告婴儿分叉支架置入术的程序结果和安全性。
我们对 2001 年 1 月 1 日至 2019 年 12 月 31 日期间因 PA 分叉狭窄而接受同时行 PA 分叉支架置入术的 12 个月以下婴儿进行了单中心回顾性研究。
17 例婴儿接受了同时行 PA 分叉支架置入术。中位年龄为 6.4 个月(1.1-10.1 个月),体重为 5.8kg(3-10.6kg)。9 例(52.9%)患者有过 PA 介入史。大多数支架置入于中央 PA(28 例,82.4%),其次是叶支(6 例,17.6%)。所有患者均接受了预装支架。每个分支的峰值梯度从 47.4±16mmHg 降至 18.7±13mmHg(P<0.0001)。右心室至体循环收缩压比值从体循环(1.0±0.3)降至略高于体循环的一半(0.58±0.2)(P=0.0001)。最小血管直径从 3.6±1.5mm 增至 6.0±1.9mm(P<0.0001)。有 4 例(23.5%)患者发生严重不良事件。无手术相关死亡。中位随访时间为 83.8 个月(5.3 个月-19.4 年)。所有患者均在中位时间 8.1 个月(2.9 个月-8.8 年)后再次行 PA 介入治疗,中位再手术时间为 19.1 个月(2.9 个月-7.5 年)。
同时行 PA 支架置入术是缓解婴儿分叉狭窄的有效策略。为了适应患者的生长,未来可能需要进行经导管介入治疗,但可能会延迟再次手术的时间。